Home › Funds › D. E. Shaw & Co › PLRX
D. E. Shaw & Co position in PLRX
PLIANT THERAPEUTICS INC COM · Health Care
Latest position (Q2 2024)10.68K sh
Reported value held$114.80K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 75.99K | $1.28M | New |
| Q4 2021 | 49.55K | $669.00K | Reduce |
| Q1 2022 | 90.11K | $632.00K | Add |
| Q2 2022 | 72.06K | $577.00K | Reduce |
| Q3 2022 | 215.31K | $4.50M | Add |
| Q4 2022 | 213.80K | $4.13M | Reduce |
| Q1 2023 | 480.51K | $12.78M | Add |
| Q2 2023 | 418.66K | $7.59M | Reduce |
| Q3 2023 | 49.00K | $849.64K | Reduce |
| Q2 2024 | 10.68K | $114.80K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PLRX
- TANG CAPITAL MANAGEMENT LLC 6.14M sh · $7.00M · Q2 2026
- ADAR1 Capital Management, LLC 5.51M sh · $6.28M · Q2 2026
- Vanguard Group 2.82M sh · $3.44M · Q4 2025
- VANGUARD CAPITAL MANAGEMENT LLC 2.44M sh · $2.78M · Q2 2026
- Two Sigma Investments 2.26M sh · $2.58M · Q2 2026
- Citadel Advisors 2.14M sh · $2.44M · Q2 2026
- Renaissance Technologies 2.05M sh · $2.34M · Q2 2026
- Monaco Asset Management SAM 1.94M sh · $2.21M · Q2 2026
- Lynx1 Capital Management LP 1.80M sh · $2.05M · Q2 2026
- BML Capital Management, LLC 1.55M sh · $1.76M · Q2 2026
- Prosight Management, LP 1.37M sh · $1.56M · Q2 2026
- Peapod Lane Capital LLC 1.31M sh · $1.49M · Q2 2026